United Therapeutics | UTHR - Ebit


United Therapeutics reported $375.6M in EBIT for its fiscal quarter ending in June of 2026.





Ebit Change Date
Amarin USD -2.26M 564K Dec/2025
Ardelyx USD -30.68M 35.78M Mar/2026
Baxter International USD 276M 210M Jun/2026
Bayer EUR 755M 2.77B Jun/2026
BioCryst Pharmaceuticals USD 98.46M 161.92M Jun/2026
Biogen USD 419.5M 663.3M Sep/2026
BioMarin Pharmaceutical USD 105.6M 24.04M Jun/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
Halozyme Therapeutics USD -63.72M 1.95M Jun/2026
Insmed USD -101.31M 98.97M Jun/2026
Ionis Pharmaceuticals USD -102.29M 15.71M Jun/2026
J&J USD 6.47B 1B Sep/2026
Lexicon Pharmaceuticals USD -14.78M 2.59M Dec/2025
Moderna USD -815M 573M Jun/2026
Omeros USD -48.15M 7.25M Sep/2023
Pfizer USD -180M 5.16B Jun/2026
PTC Therapeutics USD 146.03M 100.14M Jun/2026
Regeneron Pharmaceuticals USD 1.42B 675.7M Jun/2026
Sarepta Therapeutics USD 13.29M 345.14M Jun/2026
Teva Pharmaceutical Industries USD 235M 523M Jun/2026
United Therapeutics USD 375.6M 49.8M Jun/2026
Vertex Pharmaceuticals USD 1.27B 129.9M Jun/2026